The Estée Lauder Companies Partners with Serpin Pharma, Inc to Develop Breakthrough Skin Care Ingredients to Advance Longevity
The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory research can be applied in cosmetics to deliver significant skin care longevity benefits to consumers around the world.
The exclusive partnership will accelerate ELC’s focus on transformative product innovation by applying insights from Serpin Pharma’s two decades of anti-inflammatory research, which has yielded proprietary biotech technology demonstrating remarkable efficacy mitigating harmful inflammation and enhancing cell resiliency. Serpin Pharma identified a key portion of a superfamily of proteins called SERPINs (Serine Protease Inhibitors) that enhance the body’s natural ability to heal cells experiencing inflammation. Together, the companies are investigating how this innovative technology, which leverages the body’s innate immune response, can be harnessed to address skin irritation, aging, and sensitivity. Scientific studies are underway to demonstrate how Serpin’s technology can be applied to cosmetic products to rapidly and visibly reduce skin aging and irritation.
“This novel technology will advance our transformative innovation agenda by pushing the boundaries of breakthrough scientific discovery,” said Carl Haney, Executive Vice President, Global Innovation and Research and Development (R&D), The Estée Lauder Companies. “In partnership with Serpin Pharma, we’re exploring powerful new biological pathways and cutting-edge biotech ingredients to rapidly mitigate visible skin irritation and sensitivity for our prestige beauty consumers worldwide.”
“Serpin Pharma was founded on the principles of biomimicry and how nature solves for signs of trauma and injury,” said Cohava Gelber, PhD, MBA, Founder, Executive Chairperson and CEO, Serpin Pharma. “We’re taking a novel approach by tapping into the body’s innate mechanism for resolving inflammation. We are proud to partner with ELC to explore how our powerful biotechnology can be applied to cosmetics and skin care.”
This work builds on ELC’s decades-long leadership in longevity science, biotechnology and fermentation. The company is step-changing innovation by partnering with biotech companies across sectors to commercialize their breakthrough innovations and applying their cutting-edge technologies to developing skin care solutions for consumers. It also reinforces ELC’s commitment to creating transformative product innovation to deliver fast-to-market, on-trend innovation across in-demand subcategories, benefits, and occasions, as part of ELC’s newly unveiled Beauty Reimagined strategic vision.
With R&D and Innovation Centers around the world, ELC's scientists have multidisciplinary expertise ranging from basic science and advanced technologies to the intersections of physics, chemistry, biology, and engineering. ELC R&D has 75 years of formulation authority and is deeply integrated into the scientific community, regularly presenting at leading events, publishing in peer-reviewed journals, and partnering with leading scientists, institutions, and academia across a broad array of sectors.
About The Estée Lauder Companies
The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers, and sellers of quality skin care, makeup, fragrance, and hair care products, and is a steward of luxury and prestige brands globally. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty.
About Serpin Pharma, Inc
Serpin Pharma is a trailblazing, clinical-stage pharmaceutical company committed to the development of groundbreaking anti-inflammatory and immune-modulating therapies aimed at effectively treating diseases driven by inflammation. Located in Virginia, the company has engineered a remarkably small, highly selective peptide therapeutic that boasts an astonishing potency—300 times greater than that of its natural counterpart, Alfa-1 Antitrypsin (A1AT), in delivering anti-inflammatory and regenerative effects.
This innovative drug platform by Serpin Pharma not only halts unchecked inflammation without compromising the immune system but also promotes the repair and regeneration of cells and tissues affected by inflammation, injury, or trauma. With thirteen robust patents securing its pipeline technologies, Serpin Pharma stands on the cusp of pioneering breakthroughs that promise to reshape the landscape of therapeutic treatments.
ELC-C
View source version on businesswire.com: https://www.businesswire.com/news/home/20250225925375/en/
Contacts
Alyssa Kressel
akressel@estee.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NetApp Appoints Beth O’Callahan to Newly Defined Chief Administrative Officer Role27.2.2025 00:00:00 EET | Press release
NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced a strategic evolution in its leadership structure designed to enhance focus, strengthen collaboration, and drive execution across the business with the appointment of Beth O’Callahan, NetApp’s Chief Legal Officer (CLO), to Chief Administrative Officer (CAO). In this newly expanded role, Beth will continue overseeing Legal, Compliance, Government Relations, and Sustainability, while assuming responsibility for Human Resources, Workplace Experience, and Corporate Communications, effective March 3. By unifying these critical functions under a single leadership umbrella, NetApp aims to foster greater synergy, alignment, and operational excellence in support of its corporate strategy. Beth will also maintain her role as NetApp’s Corporate Secretary. “With Beth at the helm in this expanded capacity, we are strengthening our ability to execute with agility while fostering a more integrated and high-achieving
Marqeta to Acquire TransactPay, Strengthening Card Program Management Capabilities in the UK and Europe26.2.2025 23:06:00 EET | Press release
Marqeta (NASDAQ: MQ), the global modern card issuing platform that enables embedded finance solutions for the world’s innovators and TransactPay, a BIN Sponsorship provider that is licensed as an E-Money Institution (EMI) to issue e-money and undertake payment services in the UK and European Economic Area, today announced that they have entered into an agreement under which Marqeta will acquire TransactPay. This transaction will significantly strengthen Marqeta’s card program management capabilities in the UK and Europe. “Marqeta’s business has seen tremendous growth in Europe, and we’re excited to bring the strength and talent of TransactPay within Marqeta as we build on TransactPay’s success to date and further accelerate our offerings for customers globally,” said Marcin Glogowski, SVP Managing Director, Europe and UK CEO, Marqeta. “Our all-in-one issuing platform enables our customers to create some of the most exciting and innovative card programs available today, creating new str
Binarly Secures Patent for Machine Learning Technique to Optimize Large-Scale Binary Analysis26.2.2025 22:00:00 EET | Press release
Binarly, a leading innovator in software supply chain security, today announced that it has been granted U.S. Patent No. US 12,236,262 B1 for its groundbreaking "Machine Learning Technique for Efficiently Scheduling Tasks for Large-Scale Analysis of Binary Executables." This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250226827321/en/ U.S. Patent No. US 12,236,262 -- "Machine Learning Technique for Efficiently Scheduling Tasks for Large-Scale Analysis of Binary Executables." The patent, issued on February 25, 2025, covers a novel method for analyzing binary software efficiently by leveraging machine learning to predict peak memory usage and dynamically allocate computing resources. The patented technology extracts features from software packages (like binary executables) using advanced preprocessing techniques and machine learning models trained on extensive datasets generated from monitoring memory usage during analysis. By e
Intersolar Europe: The Time for Hybrid Power Plants Has Come26.2.2025 17:32:00 EET | Press release
The era of hybrid power plants has arrived. By combining solar, wind, and hydropower with smart storage, these plants integrate renewable electricity efficiently into the grid. As the global solar industry gathers at Intersolar Europe, discussions will focus on the latest advancements, regulations, and future prospects of hybrid power plants. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250226015598/en/ Whether Spain, Portugal or Bulgaria: Networked hybrid power plants are being built in many European countries. ©Solar Promotion GmbH Huge hybrid power plants are being built across Europe: Upon completion, a project in Portugal will comprise a 365 megawatt (MW) PV system, a wind farm with 264 MW, a 168 MW battery storage system and a 500 kilowatt (kW) electrolyzer for producing green hydrogen. A project in Spain combines photovoltaics and hydropower in a hybrid power plant. In Bulgaria, a hybrid power plant is under constru
JAPAN Pavilion to Exhibit at One of the World’s Largest Mobile Events, “MWC Barcelona 2025”26.2.2025 17:00:00 EET | Press release
From Monday, March 3 to Thursday, March 6, the JAPAN Pavilion will be exhibiting at "MWC Barcelona 2025" ("MWC"), one of the world's largest mobile-related events, held in Barcelona, Spain. The JAPAN Pavilion has been continuously organized with the support of the Ministry of Internal Affairs and Communications, supporting the global expansion of Japanese companies, particularly local enterprises, SMEs, and startups that possess excellent technological capabilities and are seeking opportunities to build networks and enhance their brand recognition in overseas markets. This year, the ITU Association of Japan will be in charge of its operation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250220101856/en/ JAPAN Pavilion (Photo: Business Wire) Featured Exhibitors and Exhibition Content This year, the JAPAN Pavilion will feature 16 companies with cutting-edge ICT technologies tailored for the 5G and Beyond 5G era, including ne
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom